Shanda Asset Management Holdings LTD Cara Therapeutics, Inc. Transaction History

Shanda Asset Management Holdings LTD

  • $1.77 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$12.34 - $17.92 $342,003 - $496,652
-27,715 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$12.39 - $17.33 $343,388 - $480,300
27,715 New
27,715 $474,000
Q3 2019

Nov 14, 2019
SELL
$18.28 - $26.91 $1.01 Million - $1.48 Million
-54,984 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$11.86 - $14.08 $652,110 - $774,174
54,984
54,984 $673,000

Others Institutions Holding CARA

# of Institutions
70
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $257M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Shanda Asset Management Holdings LTD Portfolio

Follow Shanda Asset Management Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email